Dr. Jochen ImigGroup Leader
Kim Denise FischerMaster Student
Dr. Sama Shamloo
Sama did her Ph.D. in Molecular Biology at Sapienza University of Rome, where she was a fellow of a Marie Curie network, studying novel lncRNAs involved in muscle differentiation. At CGCIII, she will work on lncRNA-miRNA interaction to explore ncRNA networks in Melanoma.
Dr. Alejandro Ulloa-Morales
Alejandro is a clinical microbiologist from Costa Rica, where he performed his thesis under the supervision of Dr. Edgardo Moreno working on the pathogenesis of Brucella abortus. After acquiring working experience in diagnostic laboratories, he immigrated to the United States and obtained his M.Sc. working with Dr. Gregg Silverman, studying the in vivo superantigenic properties of a B-cell toxin from Staphylococcus aureus. He subsequently matriculated into the Ph.D. program of New York University School of Medicine, in the Molecular Oncology training track, working in Dr. Eva Hernando's lab on the bioinformatic identification and characterization of circular RNAs in metastatic melanoma. He will continue his research on cancer biology and epitranscriptomics under the supervision of Dr. Jochen Imig at the Chemical Genomics Centre.
Stavroula Petroulia is a doctoral candidate jointly supervised by Prof. Dr. H. Waldmann and. Dr. Imig Jochen. She holds a Bachelor’s degree in General Biology from the National and Kapodistrian University of Athens. Stavroula during her studies, acquired an enthusiastic interest towards Cancer Research and therefore attended the Interdisciplinary Master program “Applications of Biology in Medicine” established by the Department of Biology and the Medical School of National and Kapodistrian University of Athens. She carried out her Master Dissertation under the supervision of Georgopoulou Urania at the lab of Molecular Virology of the Hellenic Pasteur Institute, researching on the Epigenetics of Hepatocellular Carcinoma. Stavroula is continuing her studies at the CGC delving into Genome-wide screening and functional characterization of long non-coding RNAs in melanoma and its drug resistance by using high-end technologies like CRISPR/Cas9 and miR-CLIP.